Safety and Immunogenicity of an AS03(B)-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

Dengue disease and its causative agents, the dengue viruses (DENV-1–4), cause high morbidity in tropical and subtropical regions. We evaluated three dosing regimens of the investigational tetravalent AS03(B)-adjuvanted dengue-purified inactivated vaccine (DPIV+AS03(B)). In this phase 1/2, observer-b...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Trop Med Hyg
Main Authors: Lin, Leyi, Lyke, Kirsten E., Koren, Michael, Jarman, Richard G., Eckels, Kenneth H., Lepine, Edith, McArthur, Monica A., Currier, Jeffrey R., Friberg, Heather, Moris, Philippe, Keiser, Paul B., De La Barrera, Rafael, Vaughn, David W., Paris, Robert M., Thomas, Stephen J., Schmidt, Alexander C.
Format: Artigo
Jezik:Inglês
Izdano: The American Society of Tropical Medicine and Hygiene 2020
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356407/
https://ncbi.nlm.nih.gov/pubmed/32342848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0738
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki